In breast cancer, overexpression of hyaluronan synthase 2 increases ErbB2-dependent signalling leading to disease progression [14], while suppression of hyaluronan synthase 2 leads to inhibition of tumorigenesis and progression of breast cancer [15]. This evidence concerns the gene ERBB2 and breast carcinoma.